IFNA2 and myeloid sarcoma: In detail, PBMC samples of both MS groups were assessed regarding gene expression patterns for MB21D1, TMEM173, IFNB1, IFNA2, and IFNAR1, and are displayed in Figure 5A–E as ΔΔCt relative to the HD control group [39].